A brief summary of Lipkin's research program, that he included in his presentation: Lipkin's doing a self-funded RNA Seq study with 100 patients and 100 controls, using the samples from the XMRV/p-MLV study. They are looking for biomarkers, and seeking insights into pathogenesis, and potential treatments. The investigators are Mady Hornig and Lan Quan from Columbia and two researchers from NCBI. Also, he says a metabolomics study and a proteomics study are in progress. Then there's the gut microbiome study, that we are crowdfunding. And he is also seeking funding for a study doing high-throughput sequencing of PBMC. (I assume this would be looking for pathogens.) He's also completed the cytokine study, that has some interesting results, that's awaiting publication.